Aarti Pharmalabs Ltd
NSE: AARTIPHARM BSE: 543748
₹863.80
-3.85 (0.44%)
Fri, 23 Oct 2026, 00:55 pm
Market Cap (in Cr)7856.5
PE Ratio36.75
Dividend0.40
Health Technology
Pharmaceuticals: Major
24.5KAarti Pharmalabs Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Interest expense on debt | 0 | -119.59M | -210.52M | -172.15M | -268.96M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 | 0 |
| Total assets | 2.50M | 20.40B | 22.46B | 25.83B | 29.09B |
| Total current assets | 2.50M | 10.28B | 11.63B | 13.46B | 13.22B |
| Cash and short term investments | 2.50M | 832.73M | 631.84M | 944.60M | 562.06M |
| Cash & equivalents | 2.50M | 832.73M | 121.94M | 237.78M | 70.83M |
| Short term investments | 0 | 0 | 509.90M | 706.82M | 491.23M |
| Total receivables, net | 0 | 3.89B | 4.57B | 5.31B | 5.86B |
| Accounts receivable - trade, net | — | 3.77B | 4.50B | 5.19B | 5.75B |
| Other receivables | — | 126.80M | 66.21M | 121.12M | 103.71M |
| Total inventory | 0 | 4.75B | 6.05B | 6.49B | 6.03B |
| Other current assets, total | 0 | 758.89M | 356.89M | 641.37M | 712.39M |
| Total non-current assets | 0 | 10.12B | 10.83B | 12.38B | 15.87B |
| Long term investments | 0 | 322.25M | 413.77M | 426.32M | 365.42M |
| Note receivable - long term | — | — | 58.52M | 58.52M | 73.01M |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 | 0 |
| Other investments | 0 | 322.25M | 355.25M | 367.80M | 292.40M |
| Net property/plant/equipment | 0 | 9.46B | 9.89B | 11.05B | 14.33B |
| Gross property/plant/equipment | — | 13.47B | 14.51B | 16.35B | 20.36B |
| Deferred tax assets | — | — | 19.53M | 10.46M | 23.92M |
| Net intangible assets | 0 | 241.46M | 416.30M | 770.55M | 1.00B |
| Goodwill, net | 0 | 17.81M | 17.81M | 17.81M | 17.81M |
| Other intangibles, net | 0 | 223.65M | 398.50M | 752.74M | 984.39M |
| Other long term assets, total | 0 | 89.59M | 94.38M | 113.29M | 140.28M |
| Short term debt | 0 | 3.39B | 2.15B | 2.69B | 2.98B |
| Current portion of LT debt and capital leases | 0 | 12.44M | 8.16M | 46.36M | 50.94M |
| Short term debt excl. current portion of LT debt | 0 | 3.38B | 2.14B | 2.64B | 2.93B |
| Accounts payable | 25.96K | 2.15B | 3.40B | 3.78B | 2.78B |
| Income tax payable | — | 75.00M | 35.15M | 0 | 11.45M |
| Long term debt | 0 | 20.87M | 7.15M | 166.98M | 1.15B |
| Long term debt excl. lease liabilities | 0 | 20.87M | 7.15M | 166.98M | 1.15B |
| Total equity | 2.27M | 13.86B | 15.58B | 17.57B | 19.90B |
| Shareholders' equity | 2.27M | 13.86B | 15.58B | 17.57B | 19.90B |
| Common equity, total | 2.27M | 13.86B | 15.58B | 17.57B | 19.90B |
| Other common equity | 0 | 2.29B | 1.83B | 1.86B | 1.81B |
| Total debt | 0 | 3.41B | 2.15B | 2.85B | 4.13B |
| Net debt | -2.50M | 2.58B | 1.52B | 1.91B | 3.57B |
| Change in accounts receivable | — | -1.03B | -351.72M | -1.26B | -844.33M |
| Change in taxes payable | — | — | — | — | — |
| Change in accounts payable | — | -718.62M | 1.30B | 433.48M | -569.12M |
| Change in other assets/liabilities | 45.96K | 0 | 0 | 0 | 0 |
| Sale of fixed assets & businesses | 0 | 0 | 0 | 0 | 0 |
| Purchase/sale of investments, net | 0 | -731.00K | -391.23M | -188.53M | 228.34M |
| Sale/maturity of investments | 0 | 401.00K | 0 | 5.51M | 228.34M |
| Purchase of investments | 0 | -1.13M | -391.23M | -194.04M | 0 |
| Other investing cash flow items, total | 0 | 0 | 0 | 0 | 0 |
| Issuance/retirement of debt, net | 0 | 2.72B | -1.24B | 499.93M | 1.28B |
| Issuance/retirement of long term debt | 0 | 0 | 0 | 0 | 1.00B |
| Issuance/retirement of short term debt | 0 | 2.72B | -1.24B | 499.93M | 278.61M |
| Issuance/retirement of other debt | — | — | — | — | — |
| Total cash dividends paid | 0 | 0 | -181.25M | -181.25M | -317.19M |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 | 0 |
